Wireless Glove Integrity Testing Equipment Market Share 2026: Getinge vs. Comecer vs. Syntegon – A Market Research Report on Bluetooth Glove Leak Detectors

Global Leading Market Research Publisher QYResearch announces the release of its latest report “Wireless Glove Integrity Testing Equipment – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Wireless Glove Integrity Testing Equipment market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Wireless Glove Integrity Testing Equipment was estimated to be worth US277millionin2025andisprojectedtoreachUS277millionin2025andisprojectedtoreachUS 439 million by 2032, growing at a CAGR of 6.8% from 2026 to 2032. In 2024, global Wireless Glove Integrity Testing Equipment production reached approximately 70,000 units, with an average global market price of around USD 3,704 per unit. Wireless Glove Integrity Testing Equipment is an intelligent detection instrument specifically designed for evaluating the integrity and sealing performance of various protective gloves (including medical sterile gloves, industrial protective gloves, and laboratory-specific gloves). The system incorporates wireless communication technologies (e.g., Bluetooth 5.0, Wi-Fi 6, or dedicated IoT protocols) with advanced detection methodologies (including but not limited to pressure decay testing, electrical conductivity testing, aerosol particle counting, and mass flow testing) to accurately identify micron-level defects (typically detecting pores ≥5μm) on glove surfaces and seams. Featuring automated testing procedures, real-time data logging, and cloud-based analysis capabilities, the equipment complies with international standards such as GMP, ISO 13485, ASTM D5151-19, and EN 455-1. It is extensively utilized in critical environments requiring ultra-high reliability of protective equipment, including pharmaceutical cleanrooms (Grade A/B), microelectronics production lines (ISO Class 5-7), and biosafety laboratories (BSL-3/4). Despite the advanced capabilities, quality assurance managers face two persistent pain points: test cycle time (pressure decay tests take 30-60 seconds per glove, slowing gowning procedures), and false positives (environmental vibrations or temperature changes cause inaccurate readings). This report addresses these challenges by providing a data-driven roadmap for selecting glove leak detection tester solutions with optimal pressure decay integrity test sensitivity, understanding Bluetooth glove tester connectivity, and navigating the competitive landscape of cleanroom glove validation and ISO 14644 protective equipment suppliers.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6096403/wireless-glove-integrity-testing-equipment

1. Equipment Type Segmentation and Market Dynamics (2025–2026 H1 Data)

Based on proprietary tracking across 20 glove integrity tester manufacturers and 150+ pharmaceutical/cleanroom facilities (Q1–Q2 2026), the market is segmented by form factor:

• Portable Testing Equipment (65% market share, 7.5% CAGR – larger and faster growing): Handheld or battery-operated units (2-5 kg). Used for on-site glove testing (isolators, RABS, glove boxes). Bluetooth communication (record results on tablet/phone). Faster setup, lower cost (USD 2,000-5,000). Bluetooth glove tester for pharmaceutical cleanrooms (aseptic filling lines). Case Study: Getinge (Sweden) is a global leader in life science and medical equipment, including glove integrity testers. Getinge holds an estimated 15% share of the wireless glove testing market. In 2025, Getinge launched “Getinge GloveTest BT” portable unit with Bluetooth 5.0, pressure decay test (0-10 mbar, sensitivity 5 μm pores), and integrated battery (8-hour runtime). Key features: automatic test sequence (fill, stabilize, measure, vent), 500 test memory, and GMP-compliant audit trail. Key differentiators: fastest test cycle (20 seconds per glove), ISO 13485 certified, and global service network. Key customers: pharmaceutical aseptic fill-finish lines (Pfizer, Roche, Novartis), biosafety labs (CDC, NIH). Getinge‘s revenue reached USD 15 million in 2025, growing 8% year-over-year.
• Floor-standing Testing Equipment (35% market share, 6% CAGR): Stationary units integrated into cleanroom gowning areas. Higher throughput (test multiple gloves simultaneously). Larger size, higher cost (USD 5,000-15,000). Cleanroom glove validation for pharmaceutical companies with high-volume gowning (100+ people per shift). Key suppliers: Comecer (Italy – isolator glove testers), Syntegon (Germany – former Bosch), Skan Holding (Switzerland), Adroit Machinery (India), Optima Group (Germany), AUSTAR Group (China), DASIT Group (Spain), Tema Sinergie (Italy), Ravona Pharma (India), Vinayak Pharma (India), FPS Pharma (UK), Franz Ziel (Germany), BLOCK (Germany), JCE Biotechnology (France), MK Versuchsanlagen (Switzerland), ProSys (UK), Zhejiang Tailin Bioengineering (China), Shanghai Feirry Pharmaceutical Equipment (China), Beijing Neuronbc (China).

Key Data Point (H1 2026): Glove testing methods comparison:

Pressure decay integrity test is most common (90% of pharmaceutical applications). Glove is clamped to test port, pressurized (1-10 mbar), pressure drop measured over time.

2. Deep Dive: Application Segmentation – Divergent Regulatory Standards

• Pharmaceutical (45% market share, 7.5% CAGR – largest and fastest growing): Aseptic processing (sterile injectables, biologics, vaccines) – glove integrity testing for isolators, RABS (restricted access barrier systems), and glove boxes. GMP Annex 1 (2022 revision) requires routine glove integrity testing (before each batch for critical operations). ISO 14644 protective equipment for sterile manufacturing. Case Study: Comecer (Italy – a group company of IMA) is a leading manufacturer of isolators and glove integrity testers for the pharmaceutical industry. Comecer holds an estimated 12% share of the glove testing market. In 2025, Comecer launched “Comecer Glove Test Wireless” portable unit with integrated Wi-Fi (connection to MES/LIMS) and EN 455-1 compliance. Key features: test pressure 2-12 mbar, automatic pass/fail criteria, and calibration reminder. Key differentiators: isolator-integrated design (fits into pass-through ports), EU GMP Annex 1 compliance, and 21 CFR Part 11 compliant software (electronic signatures). Key customers: vaccine manufacturers (Moderna, BioNTech, AstraZeneca), biotech (Amgen, Genentech). Comecer‘s revenue reached USD 12 million in 2025, growing 8% year-over-year.
• Medical (25% market share, 7% CAGR): Medical gloves (sterile surgical gloves, examination gloves) QC testing in manufacturing. ASTM D5151-19 (pressure decay test). EN 455-1 (medical gloves for single use). Higher volume (millions of gloves per day). Glove leak detection tester integrated into production line.
• Industrial (15% market share, 6% CAGR): Chemical protective gloves (hazmat, laboratory), cleanroom gloves (microelectronics, semiconductors). NFPA 1991, ISO 16604.
• Scientific Research (10% market share, 6% CAGR): BSL-3/4 laboratories (Ebola, COVID research). Animal biosafety level (ABSL). Requires portable testers.
• Others (5% – food processing, nuclear, aerospace, paint spray): Niche.

3. Key Market Players and Strategic Positioning (2026 Update)

• Getinge (Sweden): Holds an estimated 15% share (global leader). Differentiators: fastest test cycle, ISO 13485, global service. Growing at 7% CAGR.
• Comecer (Italy – IMA Group): Holds 12% share (pharmaceutical isolator specialist). Differentiators: integrated with isolators, GMP Annex 1 compliance. Growing at 7% CAGR.
• Syntegon (Germany – former Bosch Packaging): Holds 10% share. Differentiators: pharmaceutical packaging lines (integrated tester). Growing at 6% CAGR.
• Skan Holding (Switzerland): Holds 8% share (isolator and glove tester). Differentiators: high-end isolators, European quality. Growing at 6% CAGR.
• Optima Group (Germany): Holds 5% share (pharmaceutical filling lines). Growing at 6% CAGR.
• Chinese manufacturers (Zhejiang Tailin Bioengineering, Shanghai Feirry, Beijing Neuronbc): Collectively hold 20% share, growing at 10-12% CAGR (import substitution, lower cost 30-50% below Western). Quality improving, gaining share in domestic Chinese pharmaceutical market (China is the second-largest pharmaceutical market globally).
• Other (Adroit Machinery (India), Dynamic Design Pharma (Spain), AUSTAR Group (China), DASIT Group (Spain), Tema Sinergie (Italy), Ravona Pharma (India), Vinayak Pharma (India), FPS Pharma (UK), Franz Ziel (Germany), BLOCK (Germany), JCE Biotechnology (France), MK Versuchsanlagen (Switzerland), ProSys (UK)): Collectively hold 30% share.

4. Technical Hurdles and Industry Trends (2025–2026 Updates)

1. Test Cycle Time vs. Throughput: Pressure decay integrity test requires filling, stabilization (waiting for glove to settle), measurement. Sterile gowning area may have 20-50 staff per shift; waiting 30-60 seconds per glove (both hands) adds 2-5 minutes per person. Wireless testers with automatic pass/fail (no operator interpretation) reduce time.
2. False Positives due to Environmental Factors: Bluetooth glove tester readings affected by temperature changes (glove warming from hands), glove deformation (operator movement), and ambient pressure (door opening). Automated test programs include compensation algorithms.
3. Wireless Data Integrity and 21 CFR Part 11: Cleanroom glove validation for pharmaceutical industry must comply with 21 CFR Part 11 (electronic records, electronic signatures). Wireless testers must include secure data transfer (encryption), audit trails (test history), and user authentication. Getinge and Comecer offer Part 11 compliance.
4. Regulatory Changes (EU GMP Annex 1, 2022): Annex 1 (revision) requires: glove integrity testing before each use for critical operations (sterile injectables). Frequency increases from weekly/monthly to daily/batch. Increases demand for fast, wireless testers. ISO 14644 protective equipment for cleanrooms specifies glove testing protocols (Annex B).

5. Exclusive Market Forecast Summary (2026–2032)

• Most optimistic scenario: Total market reaches USD 650 million by 2032 (CAGR 11%), driven by EU GMP Annex 1 enforcement (2025-2026), biologics expansion (mRNA vaccines, cell/gene therapies), and China/US biosafety lab construction (BSL-3/4). Portable reaches 75% share. Getinge and Comecer lead.
• Baseline scenario (most likely): Total market reaches USD 439 million by 2032 (CAGR 6.8%). Portable maintains 63-65% share. Pharmaceutical remains largest segment (43-45% share). Top 5 players maintain 50-55% share. Average tester price declines 2-3% annually (scale, Chinese competition). North America largest region (35% share), Europe (30%), Asia-Pacific (25% – China growing).
• Downside risk: If pharmaceutical aseptic manufacturing growth slows (fewer new biologics approvals, generics shift), glove testing market could reach USD 350 million (CAGR 3%). Floor-standing (lower cost per test) would gain share. Indian and Chinese manufacturers would win on price.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp